← Back to Search

Pre-operative Opioid Education for Opioid Use Disorder

N/A
Recruiting
Led By John Corman, MD
Research Sponsored by Benaroya Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 18
Undergoing RARP at VMMC
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention/procedure/surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how pre-op education affects opioid use after prostate surgery. Patients will get different types of education before surgery & outcomes of opioid use will be studied.

Who is the study for?
This trial is for adults over 18 who are scheduled to undergo a radical prostatectomy at VMMC and have consented to participate. It's designed to see if different types of pre-surgery education can reduce the need for opioids after surgery.
What is being tested?
The study compares three ways of educating patients before surgery: usual care with varying information, a text handout, or both a text handout and video. The goal is to see which method best reduces opioid use after prostate surgery.
What are the potential side effects?
Since this trial focuses on educational interventions rather than medications, there are no direct side effects from drugs being tested. However, reduced opioid use could potentially affect pain management post-operation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I am scheduled for a robotic-assisted prostate surgery at VMMC.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
In-hospital opioid use
Post-discharge opioid use
Post-operative pain
+1 more
Secondary study objectives
Prolonged post-operative opioid use
Quality of life after undergoing surgery
Satisfaction with undergoing the surgery

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Text handout and Pre-recorded VideoExperimental Treatment1 Intervention
This group will receive limited opioid analgesia in conjunction with pre-operative education in the form of a text handout AND pre-recorded video.
Group II: Text HandoutExperimental Treatment1 Intervention
This group will receive limited opioid analgesia in conjunction with pre-operative education in the form of a text handout.
Group III: Usual CareActive Control1 Intervention
During their pre-operative visit, the usual care group will undergo usual pre-surgery patient education care dependent on their provider.

Find a Location

Who is running the clinical trial?

Benaroya Research InstituteLead Sponsor
49 Previous Clinical Trials
12,197 Total Patients Enrolled
John Corman, MD4.323 ReviewsPrincipal Investigator - Virginia Mason Medical Center
Benaroya Research Institute
3 Previous Clinical Trials
127 Total Patients Enrolled
5Patient Review
We had an excellent experience with Dr. Corman at Virginia Mason. He was thorough in answering all our questions regarding robotic prostatectomy for an intermediate risk prostate cancer. The decision was difficult because of treatment options, but we are very pleased with the surgical result. Thank you Dr. Corman!
Una Lee, MDPrincipal InvestigatorVirginia Mason Medical Center
~15 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top